© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 69.9% of KLRS shares are held by financial institutions. UBS GROUP AG is the top corporate investor, holding 5.25K shares valued at $30.36K. A 0.03% stake in Kalaris Therapeutics Inc is owned by the company. JOHNSON FINANCIAL GROUP, INC. owns 10K shares valued at $57.80K, which translates its holding of 0.05% of the stake in the company.
Among the KLRS insiders holding of 16.17% of the stake in company, HAGEN BRETT R, Chief Accounting Officer, holds the largest shares of 1.93K. , , is the second largest KLRS insider with ownership of - shares. , , stands third with possession of - shares of that stake.